Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Puccetti

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 21, 2005
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IXVladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moietiesVladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Autonomic Neuroscience : Basic & Clinical|January 6, 2009
Cardiac dysautonomia and arterial distensibility in essential hypertensivesMaurizio Acampa, Massimo Franchi, Francesca Guideri, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 19, 2003
[Lymphocyte apoptosis in non-ST segment elevation acute myocardial infarction ]Anna Laura Pasqui, Michela Di Renzo, Giovanni Bova, et al.
Journal of the American Heart Association|April 6, 2013
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotypeNatale Vazzana, Antonina Ganci, Angelo Baldassare Cefalù, et al.
Thrombosis and Haemostasis|September 6, 2003
Platelet hyperactivity after statin treatment discontinuationLuca Puccetti, Anna Laura Pasqui, Marcello Pastorelli, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjectsFulvio Bruni, Anna Laura Pasqui, Marcello Pastorelli, et al.
The American Journal of Cardiology|December 1, 2006
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic functionAlberto Palazzuoli, Jaap Deckers, Anna Calabrò, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 19, 2017
Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinomaLaura Lucarini, Lucia Magnelli, Nicola Schiavone, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 27, 2004
Redox state and carbonic anhydrase isozyme IX expression in human renal cell carcinoma: biochemical and morphological investigationsSergio A Tripodi, Maria Teresa Del Vecchio, Claudiu T Supuran, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 21, 2005
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IXVladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moietiesVladimir Garaj, Luca Puccetti, Giuseppe Fasolis, et al.
Autonomic Neuroscience : Basic & Clinical|January 6, 2009
Cardiac dysautonomia and arterial distensibility in essential hypertensivesMaurizio Acampa, Massimo Franchi, Francesca Guideri, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 19, 2003
[Lymphocyte apoptosis in non-ST segment elevation acute myocardial infarction ]Anna Laura Pasqui, Michela Di Renzo, Giovanni Bova, et al.
Journal of the American Heart Association|April 6, 2013
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotypeNatale Vazzana, Antonina Ganci, Angelo Baldassare Cefalù, et al.
Thrombosis and Haemostasis|September 6, 2003
Platelet hyperactivity after statin treatment discontinuationLuca Puccetti, Anna Laura Pasqui, Marcello Pastorelli, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjectsFulvio Bruni, Anna Laura Pasqui, Marcello Pastorelli, et al.
The American Journal of Cardiology|December 1, 2006
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic functionAlberto Palazzuoli, Jaap Deckers, Anna Calabrò, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 19, 2017
Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinomaLaura Lucarini, Lucia Magnelli, Nicola Schiavone, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 27, 2004
Redox state and carbonic anhydrase isozyme IX expression in human renal cell carcinoma: biochemical and morphological investigationsSergio A Tripodi, Maria Teresa Del Vecchio, Claudiu T Supuran, et al.
Pageof 5